Advancing knowledge and delivering products and solutions with medical, industrial and agricultural impact, via study and use of molecules, cells and organisms.
Department of Life Sciences research
Our research spans a diverse range of areas, from drug discovery science and healthcare, to evolutionary biology and biodiversity.
Understanding the molecular and genomic processes regulating cell function in development, health and disease.
Applying evolutionary concepts to fundamental questions in biology with a drive to address real world challenges through research, education, and outreach.
Optimising patient and population health outcomes through translational research.
Understanding the role of microbes, and the host response to them, in health and disease.
We transform innovation, arisen from basic research, to diagnostics and prognostics, medicines design and delivery, leading to personalised medicine.
We are a unique, cross-faculty research centre bridging biology, health and education.
Our mission is to improve cancer patient outcomes by fostering links between Bath’s scientists and clinicians.
We translate living systems into mathematical models in order to make quantitative predictions and inform biological experiments.
An interdisciplinary group from psychology, biology and biochemistry, pharmacy and pharmacology, physics and computer science and local hospital research teams.
Despite big changes to their medication regimens, people being treated for drug addiction appear to be coping well in the pandemic.
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalised medicine for cancer patients.
People low on selenium are at risk of paracetamol overdose, even when they follow dosage recommendations, according to research involving Bath.
High-quality lab procedures are even more crucial to identifying effective drugs than previously thought, new research from the University of Bath reveals.
The NHS is changing the way it writes its guidelines for giving injections in hospitals, following groundbreaking research from the University of Bath.
A Bath team has been shortlisted for this year’s Emerging Technologies Competition run by the Royal Society of Chemistry.
CiteAb, a new impartial citation-based search engine, is shaking up the $2 billion antibody industry.
Bath researchers collaborate with Sapience Therapeutics to find new treatments for cancer cell targets that don't respond to other drugs.
Bath scientists have discovered a series of protein structures that are thought to be highly relevant to the onset of Parkinson’s disease.
For the first time, scientists have added microscopic tracking devices into the interior of living cells, giving a peek into how development starts.
Overuse of antibiotics, high animal numbers and low genetic diversity from intensive farming increase the risk of animal pathogens transferring to humans.
Scientists at the Milner Centre for Evolution looked at the evolution of the virus that causes Covid19; their findings could help the design of a new vaccine.
We combine cutting-edge analytical equipment with extensive in-house expertise to provide a comprehensive material and chemical characterisation service.
A multi-user facility providing protein expression and purification services to researchers across the University and beyond.
This GW4 facility is located in Bristol and provides access to cryo-microscopy and analysis tools to study molecular processes responsible for cell function.
Bath hosted multidisciplinary CDT, exploring the boundaries between chemical sciences and engineering.
The GW4 BioMed MRC Doctoral Training Partnership aims to develop both medical and non-medical students into the next generation of medical researchers.
NERC GW4+ DTP in environmental sciences is a community of Earth, Environmental and Life Scientists.
SWBio DTP in food security & bioscience trains PhD students in the biosciences for leadership positions in academia, industry and beyond.
Find out about our PhD degrees, funding opportunities and how to apply.